Phillips Lytle on Wednesday joined the growing ranks of firms launching psychedelics practices as researchers study the compounds for possible new treatments for depression, post-traumatic stress disorder and other mental health conditions.
Special counsel Kyle Mack and partner Lisa Smith will lead the regional firm’s psychedelics and mental health therapies practice group. The firm has offices in New York, Chicago, Washington, D.C., and Ontario, Canada.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]